{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:06:04Z","timestamp":1767650764464,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.pmr.2005.12.001","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:10:36Z","timestamp":1168423836000},"page":"355-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Opioids in the Treatment of Chronic Pain: Legal Framework and Therapeutic Indications and Limitations"],"prefix":"10.1016","volume":"17","author":[{"given":"Donna","family":"Bloodworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pmr.2005.12.001_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0885-3924(95)00203-0","article-title":"Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin","volume":"11","author":"Hill","year":"1996","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.pmr.2005.12.001_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1526-4637.2001.01045.x","article-title":"Analysis of the physician variable in pain management","volume":"2","author":"Green","year":"2001","journal-title":"Pain Med"},{"key":"10.1016\/j.pmr.2005.12.001_bib3","first-page":"773","article-title":"Chronic pain and psychopathology: research findings and theoretical considerations","volume":"64","author":"Dersh","year":"2002","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.pmr.2005.12.001_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007632-199301000-00011","article-title":"Psychiatric illness and chronic low-back pain","volume":"18","author":"Polatin","year":"1993","journal-title":"Spine"},{"key":"10.1016\/j.pmr.2005.12.001_bib5","unstructured":"Drug Enforcement Administration. Pharmacist's manual: an informational outline of the Controlled Substance Act of 1970, p. 1\u20135, 32, 37\u201339, 53\u201355. Available at: http:\/\/www.deadiversion.usdoj.gov\/pubs\/manuals\/pharm2\/2pharm_manual.pdf. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib6","unstructured":"Drug scheduling. In: DEA briefs and background, drug policy, drug scheduling. Drug Enforcement Administration website. Available at: www.usdoj.gov\/dea\/pubs\/scheduling.html. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib7","unstructured":"Registrant actions\u20142004. In: Federal Register Notices. Available at: www.deadiversion.usdoj.gov\/fed_regs\/actions\/2004\/index.html. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib8","unstructured":"News releases. In: News from DEA. Drug Enforcement Administration website. Available at: www.usdoj.gov\/dea\/pubs\/pressrel\/pr041505.html. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib9","series-title":"Physician's desk reference","first-page":"3056","article-title":"Dolophine hydrochloride","year":"2002"},{"key":"10.1016\/j.pmr.2005.12.001_bib10","series-title":"Physician's desk reference","first-page":"2828","article-title":"Buprenorphine hydrochloride (Buprenex and Suboxone and Subutex)","year":"2005"},{"key":"10.1016\/j.pmr.2005.12.001_bib11","unstructured":"Intelligence bulletin: buprenorphine. Potential for abuse, September 2004, Product No. 2004\u2013L0424\u2013013, p. 1\u20134. Available at: http:\/\/www.usdoj.gov\/ndic\/pubs10\/10123\/10123t.htm. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib12","unstructured":"Database of statutes, regulations, and other policies. In: Pain and policies study group, University of Wisconsin, Comprehensive Cancer Center. Available at: http:\/\/www.medsch.wisc.edu\/painpolicy\/matrix.htm. Accessed August 27, 2005."},{"issue":"2","key":"10.1016\/j.pmr.2005.12.001_bib13","first-page":"7","article-title":"State intractable pain policy\u2014current status","volume":"7","author":"Joranson","year":"1997","journal-title":"APS Bulletin"},{"issue":"6","key":"10.1016\/j.pmr.2005.12.001_bib14","first-page":"4","article-title":"The AMA model intractable pain treatment act\u2014a critique","volume":"11","author":"Haddox","year":"1997","journal-title":"Pain Medicine Network"},{"key":"10.1016\/j.pmr.2005.12.001_bib15","unstructured":"Texas Civil Statutes. Title 71: Health Public, Article 4495c. Intractable Pain Treatment Act. Amended September 1, 1997. Available at: http:\/\/www.medsch.wisc.edu\/painpolicy\/domestic\/txipta.htm. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib16","unstructured":"Texas Administrative Code. Texas State Board of Medical Examiners, chapter 170. Authority of physician to prescribe for the treatment of pain. 22TAC\u222b\u222b170.1\u2013170.3 Available at: http:\/\/www.medsch.wisc.edu\/painpolicy\/domestic\/txmbreg.htm. Accessed August 27, 2005."},{"key":"10.1016\/j.pmr.2005.12.001_bib17","unstructured":"Health and Safety Code, chapter 481.074. In: Texas Statutes in Texas Legislature website. Available at: http:\/\/www.capitol.state.tx.us\/statutes\/hs.toc.htm. Accessed August 27, 2005."},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib18","first-page":"10","article-title":"State controlled substance laws and pain control","volume":"2","author":"Angarola","year":"1992","journal-title":"APS Bulletin"},{"key":"10.1016\/j.pmr.2005.12.001_bib19","first-page":"108","article-title":"Effect of a triplicate prescription law on prescribing of Schedule 2 drugs","volume":"41","author":"Sigler","year":"1984","journal-title":"Am J Hosp Pharm"},{"issue":"17","key":"10.1016\/j.pmr.2005.12.001_bib20","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1001\/jama.1991.03470170080028","article-title":"Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations","volume":"266","author":"Weintraub","year":"1991","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.pmr.2005.12.001_bib21","first-page":"47","article-title":"Medical ethics for physicians","volume":"118","author":"Martin","year":"2004","journal-title":"CME Resource"},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0885-3924(95)00165-4","article-title":"Chronic opioid treatment for nonmalignant pain in patients with a history of substance abuse","volume":"11","author":"Dunbar","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.pmr.2005.12.001_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3959(94)90072-8","article-title":"Physicians' attitudes and practices regarding the long-term prescribing of opioids for noncancer pain","volume":"59","author":"Turk","year":"1994","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pmr.2005.12.001_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/rapm-00115550-199419040-00002","article-title":"Survey of opioid use in chronic nonmalignant pain patients","volume":"19","author":"Jamison","year":"1994","journal-title":"Reg Anesth"},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0885-3924(00)00263-3","article-title":"Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators","volume":"21","author":"Gilson","year":"2001","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.pmr.2005.12.001_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0885-3924(01)00403-1","article-title":"Pain management, controlled substances, and state board policy: a decade of change","volume":"23","author":"Joranson","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.pmr.2005.12.001_bib27","unstructured":"Model policy for the use of controlled substances for the treatment of pain. Federation of State Medical Boards of the United States. Available at: http:\/\/www.fsmb.org\/Policy%20Documents%20and%20White%20Papers\/2004_model_pain_policy.asp. Accessed August 27, 2005."},{"year":"1999","series-title":"Opium portrait of the heavenly demon","author":"Hodgson","key":"10.1016\/j.pmr.2005.12.001_bib28"},{"key":"10.1016\/j.pmr.2005.12.001_bib29","series-title":"Drugs for pain","first-page":"83","article-title":"Opioids (Bench)","author":"Maher","year":"2003"},{"issue":"5","key":"10.1016\/j.pmr.2005.12.001_bib30","first-page":"694","article-title":"Iatrogenic addiction: the problem, its definition and history","volume":"61","author":"Musto","year":"1985","journal-title":"Bull N Y Acad Med"},{"key":"10.1016\/j.pmr.2005.12.001_bib31","first-page":"149","article-title":"Heroin","volume":"vol. 14","author":"Cohen","year":"1985"},{"year":"2004","series-title":"The great influenza\u2014the epic story of the deadliest plague in history","author":"Barry","key":"10.1016\/j.pmr.2005.12.001_bib32"},{"issue":"11","key":"10.1016\/j.pmr.2005.12.001_bib33","first-page":"799","article-title":"Editorial comment","volume":"21","author":"Lewis","year":"1915","journal-title":"American Medicine"},{"issue":"20","key":"10.1016\/j.pmr.2005.12.001_bib34","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pmr.2005.12.001_bib35","series-title":"Desk reference to the diagnostic criteria from DSM-IV-TR","first-page":"105","article-title":"Substance-related disorders","year":"2000"},{"issue":"4","key":"10.1016\/j.pmr.2005.12.001_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0885-3924(00)00195-0","article-title":"Adherence monitoring and drug surveillance in chronic opioid therapy","volume":"20","author":"Fishman","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.pmr.2005.12.001_bib37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1213\/01.ANE.0000080159.83342.B5","article-title":"Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy","volume":"97","author":"Katz","year":"2003","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00002508-199909000-00005","article-title":"Validity of self-reported drug use in chronic pain patient","volume":"15","author":"Fishbain","year":"1999","journal-title":"Clin J Pain"},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0885-3924(95)00165-4","article-title":"Chronic opioid treatment for non-malignant pain in patients with a history of substance abuse","volume":"11","author":"Dunbar","year":"1996","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.pmr.2005.12.001_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0885-3924(99)00137-2","article-title":"A chart review of the ordering and documentation of urine toxicology studies in a cancer center: do they influence patient management","volume":"19","author":"Passik","year":"2000","journal-title":"J Pain Symptom Manage"},{"year":"2002","series-title":"Urine drug tests in primary care","author":"Gourlay","key":"10.1016\/j.pmr.2005.12.001_bib41"},{"key":"10.1016\/j.pmr.2005.12.001_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0885-3924(01)00320-7","article-title":"Opioids and the treatment of chronic pain in a primary care sample","volume":"22","author":"Adams","year":"2001","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/j.1875-9114.1997.tb03059.x","article-title":"Clinical issues associated with urine testing of substances of abuse","volume":"17","author":"Eskridge","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"13","key":"10.1016\/j.pmr.2005.12.001_bib44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness","volume":"284","author":"McLellen","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pmr.2005.12.001_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.pmr.2005.12.001_bib46","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpainsymman.2003.03.003","article-title":"Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review","volume":"26","author":"Chou","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.pmr.2005.12.001_bib47","series-title":"Drugs for pain","first-page":"453","article-title":"Potential analgesic interactions","author":"Smith","year":"2003"},{"key":"10.1016\/j.pmr.2005.12.001_bib48","series-title":"Drugs for pain","first-page":"97","article-title":"Clinical pharmacology of opioids","author":"Janicki","year":"2003"},{"key":"10.1016\/j.pmr.2005.12.001_bib49","series-title":"Drugs for pain","first-page":"133","article-title":"Opioids: adverse effects and their management","author":"Elliott","year":"2003"},{"issue":"4","key":"10.1016\/j.pmr.2005.12.001_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00000433-200012000-00015","article-title":"Lethal combination of tramadol and multiple drugs affecting serotonin","volume":"21","author":"Ripple","year":"2000","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.pmr.2005.12.001_bib51","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1034\/j.1399-6576.1999.430909.x","article-title":"Opioid rotation in chronic non-malignant pain patients: a retrospective study","volume":"43","author":"Thomsen","year":"1999","journal-title":"Acta Anesthesiol Scand"},{"key":"10.1016\/j.pmr.2005.12.001_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/00000539-200004000-00029","article-title":"Opioid substitution to improve the effectiveness of chronic non-cancer pain control: a chart review","volume":"90","author":"Quang-Cantagrel","year":"2000","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.pmr.2005.12.001_bib53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","article-title":"Opioid rotation for toxicity reduction in terminal cancer patients","volume":"10","author":"DeStoutz","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.pmr.2005.12.001_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arner","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2005.12.001_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0304-3959(88)90148-0","article-title":"Can opiates relieve neuropathic pain?","volume":"35","author":"Fields","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2005.12.001_bib56","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2005.12.001_bib57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: A randomized placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2005.12.001_bib58","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pmr.2005.12.001_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Continuous release oxycodone for pain in diabetic neuropathy: a randomized control trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.pmr.2005.12.001_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2005.12.001_bib61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0885-3924(98)00070-0","article-title":"Prolonged treatment with transdermal fentanyl in neuropathic pain","volume":"16","author":"Dellemijn","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.pmr.2005.12.001_bib62","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.58.4.554","article-title":"Effects of IV morphine in central pain","volume":"58","author":"Attal","year":"2002","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.pmr.2005.12.001_bib63","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965105001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965105001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:29:14Z","timestamp":1760930954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965105001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1047965105001117"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2005.12.001","relation":{},"ISSN":["1047-9651"],"issn-type":[{"type":"print","value":"1047-9651"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids in the Treatment of Chronic Pain: Legal Framework and Therapeutic Indications and Limitations","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2005.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}